Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    0.00 (0.00%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £1.37m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Total Voting Rights

1 Dec 2010 07:00

RNS Number : 0388X
ValiRx PLC
01 December 2010
 



ValiRx Plc

("ValiRx" or the "Company")

 

Total Voting Rights

 

 

The Company wishes to announce the following information as at 30 November 2010:

 

Class of share

Total number of shares

Number of voting rights per share

Total number of voting rights per class of share

Ordinary shares of 0.1 pence each

491,299,344

1

491,299,344

 

No ordinary shares are held in treasury.

 

The above figure for total number of ordinary shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Service Authority's Disclosure and Transparency Rules.

** ENDS **

 

Contact:

 

ValiRx plc

Dr. Satu Vainikka

Tel: +44 (0) 20 3008 4416

Cairn Financial Advisers LLP

Nominated Adviser

Tony Rawlinson / Liam Murray

Tel: +44 (0) 20 7148 7900

Hybridan LLP

Broker

Claire Noyce

Tel: +44 (0) 207 7947 4350

Peckwater PR

Tarquin Edwards

Tel: +44 (0) 7879 458 364

tarquin.edwards@peckwaterpr.co.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVREANFEDSDEFEF
Date   Source Headline
12th Dec 20078:31 amPRNPhysiomics Collaboration Update
11th Dec 20077:00 amPRNValiBIO Update
27th Nov 20079:27 amPRNIssue of Equity
12th Nov 20077:00 amPRNEuropean Technology Patent for Nucleosomics
25th Oct 20074:00 pmPRNDirectorate Change
15th Oct 20077:00 amPRNLicense Agreement
28th Sep 200710:00 amPRNInterim Report
28th Sep 20077:01 amRNSTotal Voting Rights
26th Sep 20073:31 pmRNSIssue of Equity
21st Sep 20074:09 pmRNSPlacing
10th Sep 20077:00 amPRNGeneICE CRT update
17th Aug 20076:07 pmRNSAIM Rule 26 Information
8th Aug 20077:00 amPRNEuropean GeneICE Patent Granted and CRT Trials Update
31st Jul 20074:10 pmRNSTotal Voting Rights
27th Jul 200710:27 amRNSResult of AGM
19th Jul 20077:00 amPRNJoint Venture
18th Jul 20072:16 pmRNSIssue of Equity
25th Jun 20072:00 pmPRNFinal Results
12th Jun 200712:00 pmPRNValiRx partners with Clarity Imaging
14th May 20077:00 amPRNCRT / Cronos agreement extension
26th Apr 20077:00 amPRNUS GeneICE Patent Granted
18th Apr 20077:00 amPRNResearch & Development Update
4th Apr 20077:00 amPRNUniversity of Surrey - Collaborative Agreement
27th Mar 20073:45 pmRNSChange of address
15th Feb 20077:00 amPRNPhysiomics plc - Agreement
9th Jan 200712:10 pmPRNAppointment of Non-Executive Director
22nd Dec 200611:40 amRNSTotal Voting Rights
11th Dec 20067:00 amRNSIntended Grant of Patent
4th Dec 20067:00 amRNSMorphogenesis Inc
3rd Oct 20067:00 amRNSAdditional Listing
2nd Oct 20062:33 pmRNSResult of EGM
29th Sep 20061:03 pmRNSConfirmation of Share Capital
26th Sep 20064:46 pmRNSInterim Results
18th Sep 20064:36 pmRNSSchedule 1 - Azure Holdings
11th Sep 20067:00 amRNSRestoration - Azure Holdings
11th Sep 20067:00 amRNSPropsd Aqstn & Notice of EGM
4th Aug 200611:06 amRNSConvertible Loan Note Offer
18th Jul 20063:48 pmRNSConvertible Loan Note Offer
29th Jun 200612:20 pmRNSFinal Results
8th Jun 20068:25 amRNSChange of registered office
12th May 20062:54 pmRNSChange of Adviser
12th May 20062:49 pmRNSDirectorate Change
3rd Apr 20069:44 amPRNStatement re Suspension
3rd Apr 20067:01 amRNSSuspension - Azure Holdings
22nd Mar 20066:15 pmPRNChange of Registered Office
22nd Mar 20066:15 pmPRNChange of Registered Office
10th Mar 20063:45 pmPRNResult of EGM
11th Jan 20061:09 pmPRNResult of EGM
27th Sep 200512:09 pmPRNInterim Results
23rd Jun 20052:42 pmPRNFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.